Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · IEX Real-Time Price · USD
0.202
+0.009 (4.87%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Calidi Biotherapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
12.99M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 45.00K | -404.00K | -89.98% |
Dec 31, 2021 | 449.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCLDI News
- 5 days ago - Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors - Business Wire
- 21 days ago - Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13 - Business Wire
- 22 days ago - Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors - Business Wire
- 4 weeks ago - Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting - Business Wire
- 4 weeks ago - Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds - Business Wire
- 6 weeks ago - Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV - Accesswire
- 7 weeks ago - Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results - Business Wire
- 2 months ago - Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting - Business Wire